Bioulac B - Search Results

1

Kinetics of nigral degeneration in a chronic model of MPTP-treated mice.

Bezard E, Dovero S, Bioulac B, Gross CE. Bezard E, et al. Among authors: bioulac b. Neurosci Lett. 1997 Sep 26;234(1):47-50. doi: 10.1016/s0304-3940(97)00663-0. Neurosci Lett. 1997. PMID: 9347943

2

Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.

Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E. Guigoni C, et al. Among authors: bioulac bh. Eur J Neurosci. 2005 Jul;22(1):283-7. doi: 10.1111/j.1460-9568.2005.04196.x. Eur J Neurosci. 2005. PMID: 16029219

3

Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.

Gross CE, Ravenscroft P, Dovero S, Jaber M, Bioulac B, Bezard E. Gross CE, et al. Among authors: bioulac b. J Neurochem. 2003 Mar;84(6):1246-55. doi: 10.1046/j.1471-4159.2003.01600.x. J Neurochem. 2003. PMID: 12614325 Free article.

4

Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys.

Benazzouz A, Gross C, Féger J, Boraud T, Bioulac B. Benazzouz A, et al. Among authors: bioulac b. Eur J Neurosci. 1993 Apr 1;5(4):382-9. doi: 10.1111/j.1460-9568.1993.tb00505.x. Eur J Neurosci. 1993. PMID: 8261116

5

High frequency stimulation of the internal Globus Pallidus (GPi) simultaneously improves parkinsonian symptoms and reduces the firing frequency of GPi neurons in the MPTP-treated monkey.

Boraud T, Bezard E, Bioulac B, Gross C. Boraud T, et al. Among authors: bioulac b. Neurosci Lett. 1996 Aug 30;215(1):17-20. doi: 10.1016/s0304-3940(96)12943-8. Neurosci Lett. 1996. PMID: 8880743

6

Presymptomatic revelation of experimental parkinsonism.

Bezard E, Boraud T, Bioulac B, Gross CE. Bezard E, et al. Among authors: bioulac b. Neuroreport. 1997 Jan 20;8(2):435-8. doi: 10.1097/00001756-199701200-00012. Neuroreport. 1997. PMID: 9080424

7

Chronic administration of DL-allyl-glycine into the neostriatum, disorganises the firing modes of the nigral dopaminergic neurons in the rat.

Bioulac B, Benazzouz A, Burbaud P, Gross C. Bioulac B, et al. Neurosci Lett. 1997 Apr 18;226(1):21-4. doi: 10.1016/s0304-3940(97)00236-x. Neurosci Lett. 1997. PMID: 9153632

8

Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism.

Bezard E, Boraud T, Bioulac B, Gross CE. Bezard E, et al. Among authors: bioulac b. Neuroscience. 1997 Nov;81(2):399-404. doi: 10.1016/s0306-4522(97)00226-1. Neuroscience. 1997. PMID: 9300430

9

A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey.

Bezard E, Imbert C, Deloire X, Bioulac B, Gross CE. Bezard E, et al. Among authors: bioulac b. Brain Res. 1997 Aug 22;766(1-2):107-12. doi: 10.1016/s0006-8993(97)00531-3. Brain Res. 1997. PMID: 9359593

10

Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice.

Bezard E, Dovero S, Bioulac B, Gross C. Bezard E, et al. Among authors: bioulac b. Exp Neurol. 1997 Nov;148(1):288-92. doi: 10.1006/exnr.1997.6648. Exp Neurol. 1997. PMID: 9398471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters